ketanserin has been researched along with Neurotic Disorders in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Neurotic Disorders: Disorders in which the symptoms are distressing to the individual and recognized by him or her as being unacceptable. Social relationships may be greatly affected but usually remain within acceptable limits. The disturbance is relatively enduring or recurrent without treatment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frokjaer, VG | 1 |
| Mortensen, EL | 1 |
| Nielsen, FA | 1 |
| Haugbol, S | 1 |
| Pinborg, LH | 1 |
| Adams, KH | 1 |
| Svarer, C | 1 |
| Hasselbalch, SG | 1 |
| Holm, S | 1 |
| Paulson, OB | 1 |
| Knudsen, GM | 1 |
1 other study available for ketanserin and Neurotic Disorders
| Article | Year |
|---|---|
Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder.
Topics: Adolescent; Adult; Aged; Biomarkers; Character; Depressive Disorder, Major; Dominance, Cerebral; Fem | 2008 |